Klein, MD FACA FACPM Sep 23, 2025 12 min read Audience: patients and families curious about whether GLP-1based medicines (e.g., semaglutide, tirzepatide, liraglutide) might help protect brain healthespecially given growing discussion of Alzheimers disease as type 3 diabetes. The takeaway up front As a physician, I see two parallel truths emerging from recent science
Perform sample pretreatment (5% SSA treatment) quickly as in 2.
This observation is linked with the suggestion that -synuclein may play a part in the lipid homeostasis system by acting as a perilipin, participating in the formation of lipid droplets (Soste et al., 2019)
When you take a concentrated dose of BPC-157, you can boost your gut health like never beforethanks to its anti-inflammatory and protective properties
Related Services to Peptide Therapy Your Health, Your Terms Start Feeling Like Yourself Again Get your free practice guide and a $100 voucher toward your first visit
In 2024, Independence Health Group, the for-profit parent company of the nonprofit Philadelphia-based health insurance company Independence Blue Cross, reported a net loss of $239 million, despite generating $32 billion of revenue, citing a sharp increase in medical and pharmacy costs. One driver behind these losses is the rapid growth of weight-loss medications, including glucagon-like peptide-1 receptor agonists, known as GLP-1s, such as Ozempic
